Meridian bioscience stock.

Nov 20, 2018 · Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …Oct 11, 2022 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... 8 juil. 2022 ... ... Meridian Bioscience Inc. for about 2 trillion won (US$1.53 billion) in ... Korea suspends stock short selling until start of July 2024 · Most ...The estimated total pay for a Account Executive at Meridian Bioscience is $167,272 per year. ... Additional pay could include bonus, stock, commission, profit sharing or tips. The "Most Likely Range" represents values that exist within the 25th and 75th percentile of all pay data available for this role.Dec 1, 2023 · Susan D. Rolih is the Consultant at Meridian Bioscience. Markets; Tools Portfolios. Track performance, allocation, dividends, and risks. Search SEC filings. Annotate, download XLSX & look up similar tables. Stock screener. Filter, compare, and track stocks. Insiders trading. See how executives trade. Heat map. Visualize ...

19 fév. 2020 ... pylori detection and is currently evaluating additional applications of the BreathID platform. Exalenz's shares are traded on the Tel Aviv Stock ...Dec 31, 2022 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies ...

South Korean billionaire Cho Young-sik’s SD Biosensor and Seoul-based private equity firm SJL Partners said they are acquiring Nasdaq-listed diagnostics company Meridian Bioscience for $1.53 ...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, …Find Salaries by Job Title at Meridian Bioscience. 132 Salaries (for 79 job titles) • Updated Oct 29, 2023. How much do Meridian Bioscience employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips.In an all-cash transaction valued at approximately $1.53bn, a consortium led by bio-diagnostic company SD Biosensor, Inc. and investment firm SJL Partners LLC is to acquire global provider of diagnostic testing solutions and life science raw materials Meridian Bioscience, Inc. Under the terms of the definitive merger agreement, Meridian ...About Meridian. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of ...

Meridian Bioscience has 5 employees across 11 locations and $333.02 m in ... Meridian Bioscience. Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B.

Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]

Customizable interactive chart for Meridian Bioscience with latest real-time price quote, charts, latest news, technical analysis and opinions. ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener.Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian’s closing stock price on the day before the Consortium’s first offer before the market open on March 18, 2022 (closing price on March 17, 2022 was $25.67) and a premium of 16% based on ...Medical Equipment Devices. Life Science Equipment. Meridian Bioscience, Inc. (VIVO) Avg Price Recovery. 5.0 Days. Best dividend capture stocks in Nov. Payout Ratio (FWD) 0.00%. Years of Dividend Increase.Jul 6, 2022 · 100% technical buy signals. 8 new highs and up 15.79% in the last month. 4,910 investors are monitoring the stock on Seeking Alpha. ... Meridian Bioscience, Inc., a life science company ... Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Meridian Bioscience Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components. Utilizing a variety of methods, their diagnostic tests provide accuracy, simplicity and speed in the early ...

Diagnostics Solutions. Meridian Bioscience provides best-in-class diagnostic platforms, tests, education, and support to help you deliver answers. Which disease do you need to test for? Meet Revogene ®. Learn more about the innovative Revogene molecular platform.Feb 1, 2023 · Feb 1, 2023. In vitro diagnostics company SD Biosensor and private equity investment firm SJL Partners announced on Tuesday that they have completed their acquisition of Cincinnati-based life science company Meridian Bioscience. The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion. May 9, 2021 · The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation. Meridian Bioscience has 5 employees across 11 locations and $333.02 m in annual revenue in FY 2022. See insights on Meridian Bioscience including office locations, competitors, ... Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B. 2023-01-30. Revenue. $333 M. FY, 2022.Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday as it eyes a new buy point and is forming a bullish base. It comes after VIVO stock ran as much as 456% above its 2020 lows. X ...Get the latest stock quote, charts, news and analysis for Meridian Bioscience, Inc. (VIVO), a medical equipment company that develops diagnostic tests for various conditions. See …

Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …Stock split history for Meridian Bioscience (VIVO) Meridian Bioscience stock (symbol: VIVO) underwent a total of 7 stock splits. The most recent stock split occured on May 14th, 2007. One VIVO share bought prior to March 30th, 1992 would equal to 5.47509375 VIVO shares today. Stock split list. Date

Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least 365 千$ dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over 261,569$ and over the last 8 years she sold VIVO stock worth over 0$. In addition, she makes 103,333$ as Independent Director at Meridian Bioscience.Jan 31, 2023 · The estimated Net Worth of John P. Kenny is at least 17.5 百万$ dollars as of 24 June 2022. Mr Kenny owns over 74,996 units of Meridian Bioscience stock worth over 11,093,515$ and over the last 5 years he sold VIVO stock worth over 4,939,280$. In addition, he makes 1,508,705$ as Pres、 CEO & Director at Meridian Bioscience.Dive Brief: SD Biosensor said it’s postponing the closing date of its $1.53 billion merger with Meridian Bioscience to gain more time to complete financing. The deal now is scheduled to close on Jan. 31. Under the original terms, either party would have been able to terminate the deal if it was not consummated by Jan. 6.Financial performance achieved by Meridian Bioscience has been rather interesting. After seeing revenue remain almost flat, bouncing around within a range of between $200.8 million and $213.6 ...8-K 1 form8k072816.htm MERIDIAN BIOSCIENCE, INC. FORM 8-K JULY 28, 2016 SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. ... he shall be awarded options to acquire 20,000 of the Company's shares of Common Stock and he shall be entitled to receive other benefits commensurate with his new position with the …Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] 8, 2022 · South Korean billionaire Cho Young-sik’s SD Biosensor and Seoul-based private equity firm SJL Partners said they are acquiring Nasdaq-listed diagnostics company Meridian Bioscience for $1.53 ... 14 déc. 2020 ... For Immediate ReleaseChicago, IL – December 14, 2020 – Stocks in this week's article are Meridian Bioscience, Inc. VIVO, Piper Sandler ...Medical Equipment Devices. Life Science Equipment. Meridian Bioscience, Inc. (VIVO) Avg Price Recovery. 5.0 Days. Best dividend capture stocks in Nov. Payout Ratio (FWD) 0.00%. Years of Dividend Increase.Looking at the universe of stocks we cover at Dividend Channel, on 8/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/15/13.

Stock split history for Meridian Bioscience (VIVO) Meridian Bioscience stock (symbol: VIVO) underwent a total of 7 stock splits. The most recent stock split occured on May 14th, 2007. One VIVO share bought prior to March 30th, 1992 would equal to 5.47509375 VIVO shares today. Stock split list. Date

Meridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, …

Check if VIVO Stock has a Buy or Sell Evaluation. VIVO Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Meridian Bioscience Inc. News.7 juil. 2022 ... Neither acquirer issued their own statements on the transaction. Meridian's stock opened at $33.21 on the news on Thursday. The acquisition ...Looking at the universe of stocks we cover at Dividend Channel, on 5/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, …Feb 9, 2023 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... The ready-to-use qPCR and RT-qPCR master mixes have been developed for fast cycling and are designed for superior sensitivity and specificity with probe-detection technology. A combination of the latest advances in buffer chemistry and PCR enhancers, in conjunction with an antibody or chemical-mediated DNA polymerase promote rapid, consistently ...Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least 365 千$ dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over 261,569$ and over the last 8 years she sold VIVO stock worth over 0$. In addition, she makes 103,333$ as Independent Director at Meridian Bioscience.Meridian Bioscience is a well-established global provider of innovative diagnostics products, covering the whole spectrum of services from manufacturing to marketing.Check if VIVO Stock has a Buy or Sell Evaluation. VIVO Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Meridian Bioscience Inc. News.Meridian Bioscience has thrived during the COVID-19 pandemic. Can this stock go much higher, or is it time to cash out? Meridian Bioscience ( VIVO) ran past its 52-week high last week, closing on ...Jan 31, 2023 · The estimated Net Worth of Dwight E Ellingwood is at least $379 Thousand dollars as of 4 October 2018. Mr. Ellingwood owns over 1,000 units of Meridian Bioscience stock worth over $271,760 and over the last 9 years he sold VIVO stock worth over $0. In addition, he makes $107,000 as Independent Director at Meridian Bioscience.Under the terms of the merger, Meridian shareholders have the right to receive $34.00 per share in cash. Meridian stock will no longer be traded on the NASDAQ Global Select Market. Meridian will continue to operate as an independent entity, under new ownership, headquartered in Cincinnati, Ohio. About SD Biosensor, Inc.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...

Meridian Bioscience is committed to working with and providing reasonable accommodation to individuals with physical and mental disabilities. If you need special assistance or an accommodation while seeking employment, please email [email protected] or call 513-271-3700. We will make a …27 Apr 2018 ... Meridian Bioscience Brand Essence Video. 1.1K views · 5 years ago ...more. Meridian Bioscience. 350. Subscribe. 350 subscribers.Meridian Bioscience Inc stock price live 33.97, this page displays NASDAQ VIVO stock exchange data. View the VIVO premarket stock price ahead of the market session or …Instagram:https://instagram. collectibles insurance companymost traded etfsfinancial planner rockford ilbuy bank stocks Jul 26, 2022 · A South Korean buyer consortium is acquiring US diagnostic test kit maker Meridian Bioscience (NASDAQ:VIVO). The offer is $34 per share in cash or a total of ~$1.53bn. The offer is $34 per share ... nasdaq abnb comparepharma penny stocks Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least $365 Thousand dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over $261,569 and over the last 8 years she sold VIVO stock worth over $0. In addition, she makes $103,333 as Independent Director at Meridian Bioscience.The opportunity to support authentic relationships is what motivates our teams to create accurate solutions that span the range from discovery to diagnosis. We work hard every day to build genuine connections with all of our customers because even in the complex world of healthcare, the solution is simple. We’re here to help people, and we ... list of preferred stocks SD Biosensor and SJL Partners agreed to acquire Meridian Bioscience in an all-cash deal valued at about $1.53 billion, according to a statement by Cincinnati-based Meridian on Thursday.. SD Biosensor, a diagnostics company headquartered in South Korea, along with private equity firm SJL Partners, would create a new affiliate for the …Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least 1.07 百万$ dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over 958,769$ and over the last 14 years he sold VIVO stock worth over 0$. In addition, he makes 114,667$ as Independent Director at Meridian Bioscience.